TTrialPathMatch Me to Trials
← Back to trials
RecruitingHypertensionPure Autonomic FailureMultiple System Atrophy

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

Eligible age

18–80 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Patients with autonomic failure are characterized by disabling orthostatic hypotension (low blood pressure on standing), and at least half of them also have high blood pressure while lying down (supine hypertension). Exposure to heat, such as in hot environments, often worsens their orthostatic hypotension. The causes of this are not fully understood. The purpose of this study is to evaluate whether applying local heat over the abdomen of patients with autonomic failure and supine hypertension during the night would decrease their nocturnal high blood pressure while lying down. This will help us better understand the mechanisms underlying this phenomenon, and may be of use in the treatment of supine hypertension.

Sponsor: Vanderbilt University Medical Center

You may qualify if…

  • ✓ Male and female patients, between 18-80 yrs., with primary autonomic failure (Parkinson Disease, Multiple System Atrophy, and Pure Autonomic Failure) and supine hypertension. Supine hypertension will be defined as SBP≥150 mmHg.
  • ✓ Patients able and willing to provide informed consent.

You may not qualify if…

  • ✕ Pregnancy
  • ✕ Significant cardiac, renal or hepatic illness, or with contraindications to administration of pressor agents or with other factors, which in the investigator's opinion would prevent the subject from completing the protocol including clinically significant abnormalities in clinical, mental or laboratory testing.

Where it's recruiting

Tennessee

Nashville

Source: ClinicalTrials.gov · NCT03042988 · last updated 2026-01-16

Overnight Trials With Heat Stress in Autonomic Failure Patients With S · TrialPath